• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,320.00(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Ather Energy
    1,782.05 1,782.05(%)
  • Laurus Labs
    2,392.00 2,392.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 824.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 33.21(%)
  • Godrej Consumer
    777.65 777.65(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 47.26(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Titan Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4349.0
  • ISIN : INE150C01029
339.85 -21 (-5.72%)
  • As on 01 Nov 2026 (EOD)

  • Today’s Low

    335.40

  • Today’s High

    364.95

  • Open

    364.90

  • Perv Close

    360.45

  • 52W Low

    137.12

  • 52W High

    444.52

Key Indicators

  • P/E(TTM)

    57.12

  • Mar.Cap (₹Cr.)

    1,755.26

  • Div & Yield %

    0.12

  • Book Value(₹)

    33.08

  • Debt-Equity Ratio

    -5.72

  • AGM Date

    30-Oct-2026

  • EPS

    5.95

  • P/E Ratio

    57.12

Financials Ratios

  • Debt-Equity Ratio

    0.07

  • Mar.Cap (₹Cr.)

    1,755.26

  • RONW (%)

    19.44

  • ROCE (%)

    24.84

Score Board

  • Equity (₹ in Cr.)

    10.33

  • BV (₹)

    33.10

  • Sales( ₹ in Cr.)

    206.19

  • NP (in Cr.)

    27.45

  • NP Var(%)

    50.0

  • Div%

    25.0

  • CPS (₹)

    6.30

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    1,755.26

  • 52 Week High

    444.52

  • 52 Week Low

    137.12

  • Price BSE

    340.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,755.26

  • P/C Ratio

    54.20

  • P/E Ratio

    64.00

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 206.19 156.45 164.07 144.00 123.55 122.46
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 206.19 156.45 164.07 144.00 123.55 122.46
Other Income 5.41 3.91 1.75 1.94 0.94 0.75
Stock Adjustments 2.97 2.85 5.29 0.93 0.17 2.23
Total Income 214.57 163.21 171.11 146.87 124.66 125.44
EXPENDITURE :            
Raw Materials 103.99 79.34 85.33 74.61 61.64 57.58
Power and Fuel Cost 12.76 9.83 10.24 8.98 6.67 4.10
Employee Cost 32.36 26.38 23.71 18.21 14.24 11.08
Other Manufacturing Expenses 5.15 3.92 4.10 3.44 2.96 3.77
Selling and Administration Expenses 15.04 13.44 10.75 9.21 6.42 5.66
Miscellaneous Expenses 1.26 0.96 0.95 0.96 0.52 1.05
Employee Benefit Expenses 32.36 26.38 23.71 18.21 14.24 11.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 170.56 133.88 135.07 115.42 92.46 83.23
Operating Profit 44.01 29.34 36.03 31.47 32.21 42.20
Interest 0.91 0.80 1.17 0.75 0.87 1.33
Gross Profit 43.10 28.54 34.86 30.72 31.34 40.87
Depreciation 4.93 4.17 3.33 2.60 2.37 2.10
Profit Before Tax 38.17 24.37 31.53 28.12 28.97 38.77
Current Tax 9.89 5.97 7.76 7.18 7.35 9.86
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.84 0.12 0.11 -0.09 -0.07 0.13
Reported Net Profit 27.45 18.27 23.66 21.02 21.68 28.77
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.24
Adjusted Net Profit 27.45 18.27 23.66 21.02 21.68 29.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 127.80 111.18 89.00 69.22 48.77 20.83
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.65 1.65 1.49 1.24 1.24 0.83
P & L Balance carried down 153.59 127.80 111.18 89.00 69.22 48.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 25.00 20.00 20.00 18.00 15.00 15.00
Dividend Per Share(Rs) 0.50 2.00 2.00 1.80 1.50 1.50
Earnings Per Share-Unit Curr 6.64 22.11 28.64 25.44 26.24 34.82
Earnings Per Share(Adj)-Unit Curr 5.31 3.54 4.58 4.07 4.20 5.57
Book Value 41.35 175.63 155.43 128.38 104.36 79.65
Book Value(Adj)-Unit Curr 33.08 28.10 24.87 20.54 16.70 12.74

Shareholding Pattern

  • Promoter Group

    55.78%

  • Public Share Holding

    44.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 20,603,050 49.86 20,603,050 3
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 20,603,050 49.86 20,603,050 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,444,470 5.92 2,444,470 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,444,470 5.92 2,444,470 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,800 0.01 2,800 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,800 0.01 2,800 1
2] Non Institution
Bodies Corporate 1,404,227 3.40 1,404,227 41
Clearing Members 1,439 0.00 1,439 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 652,973 1.58 652,973 393
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 369,487 0.89 369,487 208
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,980,574 4.79 1,980,574 6
Individuals holding nominal share capital up to Rs. 1 lakh 9,656,188 23.37 9,656,188 18,374
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 3,873,525 9.37 3,873,525 1
Sub Total 18,268,180 44.21 18,268,180 19,036
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 41,318,500 100.00 41,318,500 19,049

Company Background

Titan Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Titan Biotech Ltd
  • BSE Code : 4349.0
  • ISIN : INE150C01029

  • Incorporation Year

    1992

  • Registered Office

    A-902 A RIICO Industrial Area
    Phase III Alwar District, Bhiwadi,
    Rajasthan-301019

  • Telephone

    91-011-27355742/27674615

  • FAX

    91-011-47619811

  • Chairman

    Rohit Jain

  • Managing Director

    Naresh Kumar Singla

  • Company Secretary

    CHARANJIT SINGH

  • Auditor

    A N S K & Associates

  • Face Value

    2

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99,
    Madangir Behind LSC,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Titan Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Titan Biotech 339.85 211.60 206.19 57.12 23.81
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77